Product Information
VALGANCICLOVIR 450 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $2.0151 per EA under NDC 64380015301. Its NADAC has been published 195 times since Nov 30, 2022.
FDA first approved this application on Nov 4, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Valganciclovir hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
450 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380015301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VALGANCICLOVIR HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200790FDA Approved
11/4/2014
TE Code
AB
On Market Since
9/12/2022
Pharmacological Classes
Price Statistics
The NADAC for VALGANCICLOVIR 450 MG TABLET has been published 195 times since Nov 30, 2022, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0151 per EA |
|---|---|
| All-time high | $3.2719 (Oct 11, 2023) |
| All-time low | $1.7596 (Nov 20, 2024) |
| 52-week high | $2.5006 |
| 52-week low | $1.8426 |
| Median price | $2.3981 |
| Average price | $2.4249 |
| Largest weekly change | -29.7% (Apr 17, 2024) |
| Weeks tracked | 195 |
| Tracking since | Nov 30, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VALGANCICLOVIR 450 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALGANCICLOVIR 450 MG TABLET, manufactured by Strides Pharma Inc., is $2.0151 per EA (NDC 64380015301), effective Aug 19, 2026.
How has the price of VALGANCICLOVIR 450 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALGANCICLOVIR 450 MG TABLET has declined 31.7%. It has been tracked across 195 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for VALGANCICLOVIR 450 MG TABLET?
Since Nov 30, 2022, the NADAC for VALGANCICLOVIR 450 MG TABLET has ranged from a low of $1.7596 (Nov 20, 2024) to a high of $3.2719 (Oct 11, 2023), with a median of $2.3981 per EA.
Are there cheaper alternatives to VALGANCICLOVIR 450 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VALGANCICLOVIR 450 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VALGANCICLOVIR 450 MG TABLET?
VALGANCICLOVIR 450 MG TABLET (NDC 64380015301) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.